399 related articles for article (PubMed ID: 9369370)
1. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
2. Characterization of angiotensin II antagonism displayed by SK-1080, a novel nonpeptide AT1-receptor antagonist.
Lee SH; Jung YS; Lee BH; Yun SI; Yoo SE; Shin HS
J Cardiovasc Pharmacol; 1999 Mar; 33(3):367-74. PubMed ID: 10069670
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs.
Shibasaki M; Fujimori A; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):175-84. PubMed ID: 9369371
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
Shibouta Y; Inada Y; Ojima M; Wada T; Noda M; Sanada T; Kubo K; Kohara Y; Naka T; Nishikawa K
J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
Criscione L; de Gasparo M; Bühlmayer P; Whitebread S; Ramjoué HP; Wood J
Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.
Robertson MJ; Barnes JC; Drew GM; Clark KL; Marshall FH; Michel A; Middlemiss D; Ross BC; Scopes D; Dowle MD
Br J Pharmacol; 1992 Dec; 107(4):1173-80. PubMed ID: 1467838
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
[TBL] [Abstract][Full Text] [Related]
8. The in vitro pharmacological profile of KR31080, a nonpeptide AT1 receptor antagonist.
Hong KW; Kim CD; Lee SH; Yoo SE
Fundam Clin Pharmacol; 1998; 12(1):64-9. PubMed ID: 9523186
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
Lee BH; Lee SH; Jung YS; Seo HW; Yoo SE; Shin HS
J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profiles of a novel non-peptide angiotensin II type I receptor antagonist HR720 in vitro and in vivo.
Jin D; Song K; Oka Y; Takai S; Shiota N; Miyazaki M
Jpn J Pharmacol; 1997 Nov; 75(3):259-66. PubMed ID: 9434257
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological profile of TH-142177, a novel orally active AT1-receptor antagonist.
Nozawa Y; Haruno A; Oda N; Yamasaki Y; Matsuura N; Miyake H; Yamada S; Kimura R
Fundam Clin Pharmacol; 1997; 11(5):395-401. PubMed ID: 9342592
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation.
Virone-Oddos A; Desangle V; Provost D; Cazes M; Caussade F; Cloarec A
Br J Pharmacol; 1997 Feb; 120(3):488-94. PubMed ID: 9031754
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
Ohlstein EH; Brooks DP; Feuerstein GZ; Ruffolo RR
Pharmacology; 1997 Nov; 55(5):244-51. PubMed ID: 9399334
[TBL] [Abstract][Full Text] [Related]
15. Effects of YM358, an angiotensin II type 1 (AT1) receptor antagonist, and enalapril on blood pressure and vasoconstriction in two renal hypertension models.
Tokioka T; Shibasaki M; Fujimori A; Matsuda-Satoh Y; Uchida W; Inagaki O; Yanagisawa I
Biol Pharm Bull; 2000 Feb; 23(2):174-81. PubMed ID: 10706380
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of repeatedly administered YM358, an angiotensin AT1-receptor antagonist, in stroke-prone spontaneously hypertensive rats.
Yamaguchi N; Fujimoto K; Fujii T; Suzuki T; Kawashima K
Jpn J Pharmacol; 1997 Jan; 73(1):83-91. PubMed ID: 9032137
[TBL] [Abstract][Full Text] [Related]
17. BMS-180560, an insurmountable inhibitor of angiotensin II-stimulated responses: comparison with losartan and EXP3174.
Dickinson KE; Cohen RB; Skwish S; Delaney CL; Serafino RP; Poss MA; Gu Z; Ryono DE; Moreland S; Powell JR
Br J Pharmacol; 1994 Sep; 113(1):179-89. PubMed ID: 7812609
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
Wong PC; Quan ML; Saye JM; Bernard R; Crain EJ; McCall DE; Watson CA; Zaspel AM; Smith RD; Wexler RR
J Cardiovasc Pharmacol; 1995 Sep; 26(3):354-62. PubMed ID: 8583775
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacology of a novel non-peptide angiotensin II-receptor antagonist, E4177.
Okunishi H; Song K; Oka Y; Kobayashi T; Kawamoto T; Ishihara H; Mori N; Miyazaki M
Jpn J Pharmacol; 1993 Jul; 62(3):239-44. PubMed ID: 8411773
[TBL] [Abstract][Full Text] [Related]
20. Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.
Wong PC; Herblin WF; Barbera FA; Bernard R; Bozarth TA; Watson CA; Gibson RE
Clin Exp Hypertens; 1996 Feb; 18(2):189-200. PubMed ID: 8869000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
